Arrowhead Pharmaceuticals ARWR
NASDAQ ARWR
$64.19 -0.60 (-0.93%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arrowhead Pharmaceuticals (ARWR) Return on Assets [ROA] (2011 - 2026)

Updated

Arrowhead Pharmaceuticals' Return on Assets [ROA] came in at -12.43% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 1.64 percentage points from -10.79% a year earlier but up 1.62 percentage points from the prior quarter.

Analysis

Arrowhead Pharmaceuticals (ARWR) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Return on Assets [ROA] was 2.39%, up 66.38 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of +21.77 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, Return on Assets [ROA] was -64.00% in FY2024 (-35.28 pp), -28.72% in FY2023 (-3.54 pp), -25.18% in FY2022 (-2.32 pp) and -22.85% in FY2021 (-3.47 pp).
  • The five-year range for quarterly Return on Assets [ROA] is -60.39% (fiscal Q2 2024) to 15.63% (fiscal Q1 2026).
  • Year-over-year, Return on Assets [ROA] increased in four of the last eight quarters, with an average year-over-year change of +22.70 percentage points.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q1 2026 (a gain of 75.95 percentage points), and the weakest in fiscal Q2 2024 (a drop of 43.32 percentage points).
  • Business Quant data shows ARWR's Return on Assets [ROA] at -14.04% (Q2 2026), 15.63% (Q1 2026) and 2.18% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Arrowhead Pharmaceuticals 9.06 Bn 3.84 Bn - -12.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.43%
Mar 31, 2026 -14.04%
Dec 31, 2025 15.63%
Sep 30, 2025 2.18%
Jun 30, 2025 -10.79%
Mar 31, 2025 -11.96%
Dec 31, 2024 -60.32%
Sep 30, 2024 -60.26%
Jun 30, 2024 -59.53%
Mar 31, 2024 -60.39%
Dec 31, 2023 -43.52%
Sep 30, 2023 -26.81%
Jun 30, 2023 -21.84%
Mar 31, 2023 -17.07%
Dec 31, 2022 -19.63%
Sep 30, 2022 -24.45%
Jun 30, 2022 -21.15%
Mar 31, 2022 -16.66%
Dec 31, 2021 -27.14%
Sep 30, 2021 -19.49%
API Access

Arrowhead Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ARWR&period=max&api_key=YOUR_API_KEY